Nationwide Q Fever Hospitalizations in Italy, 2014-2023: Evidence of Underrecognition and a Sardinian Hotspot.
10 affiliations
- 1Primary Care Research Unit, Madrid Health Service (SERMAS), Madrid, Spain.
- 2Biomedical Sciences and Public Health Doctorate Program, UNED - ENS Mixed Research Institute (IMIENS), Madrid, Spain.
- 3National Centre of Microbiology (ISCIII-CNM), Carlos III Health Institute, Madrid, Spain.
- 4Consortium for Biochemical Research in Infectious Diseases (CIBERINFEC), Madrid, Spain.
- 5Dipartimento Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
- 6European Commission, Joint Research Centre (JRC), Seville, Spain.
- 7Facultad de Veterinaria, Universidad Alfonso X el Sabio (UAX), Madrid, Spain.
- 8Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
- 9National Centre of Epidemiology (ISCIII-CNE), Carlos III Health Institute, Madrid, Spain.
- 10Consortium for Biochemical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Abstract
Background
Q fever is a zoonotic disease caused by Coxiella burnetii. In Italy, serologic evidence shows exposure in humans and livestock, but surveillance data are sparse, and underreporting is likely. We aimed to characterize Q fever-related hospitalizations in Italy during 2014-2023 and examine environmental risk correlates.Method
We conducted a nationwide retrospective study using the Italian National Hospital Discharge Database. Hospitalizations with ICD-9-CM code 083.0 as primary or secondary diagnosis were included. We calculated hospitalization rates by age, sex, and region and described clinical characteristics. We linked hospitalizations with climatic, livestock, and land-use data; for Sardinia, we fitted Bayesian spatial regression models including bovine, ovine, and caprine density, temperature, precipitation, and land use.Results
We identified 428 hospitalizations (67% male), corresponding to a rate of 0.07 per 100 000 person-years. Rates were highest in children and older adults. The overall case fatality ratio was 2.4%. The most frequent Q fever-related concomitant diagnosis was pneumonia. Sardinia had the highest case count and adjusted hospitalization rate, 7-fold the national rate (0.55 vs 0.07). Spatial models for Sardinia showed hotspots in the north of the island and a 12% increase in spatial hospitalization risk per 10 bovine heads/km² (adjusted relative risk 1.12, 95% credible interval 1.03-1.24).Conclusions
Q fever causes an underrecognized burden of hospitalizations in Italy, with marked regional heterogeneity and a Sardinian hotspot associated with high cattle density areas. Clinical awareness, surveillance, and One Health interventions are warranted in high-risk areas.
Related
- Nationwide trends in dementia subtypes and in-hospital mortality among hospitalizations with type 2 diabetes in Spain, 2021–2024: A focus on sex disparities
- The Enigma of Finnish and Sardinian Type 1 Diabetes Incidence: Where Population History Meets Genetics
- A Novel NKAP Gene Frameshift Mutation in a Sardinian Family Causes Early Cell Death and Secondary Skewed X-Chromosome Inactivation and Associates with Multiple Male Miscarriages
- Socioeconomic deprivation and post-discharge mortality in heart failure: evidence from a nationwide universal health coverage system
- Evidence for patterns of colonization risk in the nationwide hospitalized patient network in France
BibTeX
@article{cifo2026nationwide,
title = {{Nationwide Q Fever Hospitalizations in Italy, 2014-2023: Evidence of Underrecognition and a Sardinian Hotspot.}},
author = {Daniel Cifo and David González-Barrio and Alberto Mateo-Urdiales and Patrizio Pezzotti and Alessandra Ciervo and Angela Fanelli and Alda Natale and Diana Gómez-Barroso and Rosa M Estévez-Reboredo},
journal = {Open forum infectious diseases},
year = {2026},
month = oct,
doi = {10.1093/ofid/ofag667},
url = {https://europepmc.org/article/MED/42909273},
note = {CC BY},
}
RIS
TY - JOUR
TI - Nationwide Q Fever Hospitalizations in Italy, 2014-2023: Evidence of Underrecognition and a Sardinian Hotspot.
AU - Daniel Cifo
AU - David González-Barrio
AU - Alberto Mateo-Urdiales
AU - Patrizio Pezzotti
AU - Alessandra Ciervo
AU - Angela Fanelli
AU - Alda Natale
AU - Diana Gómez-Barroso
AU - Rosa M Estévez-Reboredo
PY - 2026
DA - 2026/10/21
JO - Open forum infectious diseases
DO - 10.1093/ofid/ofag667
UR - https://europepmc.org/article/MED/42909273
AB - Background Q fever is a zoonotic disease caused by Coxiella burnetii. In Italy, serologic evidence shows exposure in humans and livestock, but surveillance data are sparse, and underreporting is likely. We aimed to characterize Q fever-related hospitalizations in Italy during 2014-2023 and examine environmental risk correlates.Method We conducted a nationwide retrospective study using the Italian National Hospital Discharge Database. Hospitalizations with ICD-9-CM code 083.0 as primary or secondary diagnosis were included. We calculated hospitalization rates by age, sex, and region and described clinical characteristics. We linked hospitalizations with climatic, livestock, and land-use data; for Sardinia, we fitted Bayesian spatial regression models including bovine, ovine, and caprine density, temperature, precipitation, and land use.Results We identified 428 hospitalizations (67% male), corresponding to a rate of 0.07 per 100 000 person-years. Rates were highest in children and older adults. The overall case fatality ratio was 2.4%. The most frequent Q fever-related concomitant diagnosis was pneumonia. Sardinia had the highest case count and adjusted hospitalization rate, 7-fold the national rate (0.55 vs 0.07). Spatial models for Sardinia showed hotspots in the north of the island and a 12% increase in spatial hospitalization risk per 10 bovine heads/km² (adjusted relative risk 1.12, 95% credible interval 1.03-1.24).Conclusions Q fever causes an underrecognized burden of hospitalizations in Italy, with marked regional heterogeneity and a Sardinian hotspot associated with high cattle density areas. Clinical awareness, surveillance, and One Health interventions are warranted in high-risk areas.
SN - 2328-8957
ER -